Skip to main content
. 2022 Jun 15;10(6):1414. doi: 10.3390/biomedicines10061414
APCs antigen-presenting cells
BEDs biologically effective doses
CTL cytotoxic T cells
CTLA-4 cytotoxic T cell-associated antigen 4
CSF-1R colony-stimulating factor 1 receptor
DAMP damage-associated molecular patterns
DC dendritic cells
DSBs double-strand breaks
GM-CSF granulocyte colony-stimulating factor
ICD immunogenic cell death
ICI immune checkpoint inhibitor
IFN Interferon
LC local control
LF local failure
MDSCs myeloid-derived suppressor cells
MHC major histocompatibility complex
NK natural killer
NSCLC non-small cell lung cancer
PD-1 programmed cell death protein 1
PD-L1 programmed cell death-ligand 1
PFS progression-free survival
RT Radiation therapy
SRT stereotactic radiation therapy
SRS Radiosurgery
SBRT stereotactic body radiation therapy
TAA tumor-associated antigen
TAMs tumor-associated macrophage
TCR T cell receptor
TILs tumor-infiltrating lymphocytes
TME tumor microenvironment